loading page

COVID-19 in pediatric cancer: where are the brain tumors?
  • Rebecca Ronsley,
  • Eric Bouffet
Rebecca Ronsley
University of British Columbia Faculty of Medicine
Author Profile
Eric Bouffet
Hospital for Sick Children
Author Profile

Abstract

Treatment of pediatric oncology patients generally results in significant immunosuppression and when the COVID-19 pandemic arose, there was concern among pediatric oncologists about the implications of this virus. We reviewed the literature and describe all pediatric oncology patients with COVID-19 reported worldwide. Within this review, it is striking that CNS tumors are reported at low numbers (27/466 pediatric oncology patients with COVID-19). This may be related to decreased inpatient care when compared to other pediatric cancers. Additional work is needed to understand the risk of infection in this population and gain insight into the effect on delivery of oncology care.

Peer review status:UNDER REVIEW

30 Mar 2021Assigned to Editor
30 Mar 2021Submission Checks Completed
30 Mar 2021Submitted to Pediatric Blood & Cancer
08 Apr 2021Reviewer(s) Assigned